Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Manley

Showing results (351-360 of 378) with videos related to

Pageof 38
Sort By:
NPJ Precision Oncology|January 12, 2026
ShinyEvents: harmonizing longitudinal data for real-world survival estimationAlyssa Obermayer, Joshua Davis, Divya Priyanka Talada, et al.
Clinical Genitourinary Cancer|October 1, 2024
A Single Institution Experience in the Management of Localized Neuroendocrine Carcinoma of the BladderCasey Liveringhouse, Austin J Sim, Jingsong Zhang, et al.
Journal of Medicinal Chemistry|April 18, 2003
Indole naphthyridinones as inhibitors of bacterial enoyl-ACP reductases FabI and FabKMark A Seefeld, William H Miller, Kenneth A Newlander, et al.
Journal for Immunotherapy of Cancer|May 15, 2023
Geospatial characterization of immune cell distributions and dynamics across the microenvironment in clear cell renal cell carcinomaNicholas H Chakiryan, Youngchul Kim, Anders Berglund, et al.
Biorxiv : the Preprint Server for Biology|July 15, 2025
Spatial analysis reveals a novel inflammatory tumor transition state which promotes a macrophage-driven induction of sarcomatoid renal cell carcinomaAllison M May, Suguru Kadomoto, Claire Williams, et al.
JAMA Pediatrics|August 19, 2024
Whole-of-Life Inclusion in Bayesian Adaptive Platform Clinical TrialsAnita J Campbell, Keerthi Anpalagan, Emma J Best, et al.
Bioorganic & Medicinal Chemistry Letters|January 30, 2017
Discovery of MK-1832, a Kv1.5 inhibitor with improved selectivity and pharmacokineticsScott E Wolkenberg, M Brad Nolt, Mark T Bilodeau, et al.
Genome Biology|December 5, 2024
Increased spatial coupling of integrin and collagen IV in the immunoresistant clear-cell renal-cell carcinoma tumor microenvironmentAlex C Soupir, Mitchell T Hayes, Taylor C Peak, et al.
Journal of Medicinal Chemistry|June 11, 2014
Maximizing diversity from a kinase screen: identification of novel and selective pan-Trk inhibitors for chronic painShawn J Stachel, John M Sanders, Darrell A Henze, et al.
Biorxiv : the Preprint Server for Biology|November 28, 2023
Increased spatial coupling of integrin and collagen IV in the immunoresistant clear cell renal cell carcinoma tumor microenvironmentAlex C Soupir, Mitchell T Hayes, Taylor C Peak, et al.
Pageof 38

Showing results (351-360 of 378) with videos related to

Sort By:
Pageof 38
NPJ Precision Oncology|January 12, 2026
ShinyEvents: harmonizing longitudinal data for real-world survival estimationAlyssa Obermayer, Joshua Davis, Divya Priyanka Talada, et al.
Clinical Genitourinary Cancer|October 1, 2024
A Single Institution Experience in the Management of Localized Neuroendocrine Carcinoma of the BladderCasey Liveringhouse, Austin J Sim, Jingsong Zhang, et al.
Journal of Medicinal Chemistry|April 18, 2003
Indole naphthyridinones as inhibitors of bacterial enoyl-ACP reductases FabI and FabKMark A Seefeld, William H Miller, Kenneth A Newlander, et al.
Journal for Immunotherapy of Cancer|May 15, 2023
Geospatial characterization of immune cell distributions and dynamics across the microenvironment in clear cell renal cell carcinomaNicholas H Chakiryan, Youngchul Kim, Anders Berglund, et al.
Biorxiv : the Preprint Server for Biology|July 15, 2025
Spatial analysis reveals a novel inflammatory tumor transition state which promotes a macrophage-driven induction of sarcomatoid renal cell carcinomaAllison M May, Suguru Kadomoto, Claire Williams, et al.
JAMA Pediatrics|August 19, 2024
Whole-of-Life Inclusion in Bayesian Adaptive Platform Clinical TrialsAnita J Campbell, Keerthi Anpalagan, Emma J Best, et al.
Bioorganic & Medicinal Chemistry Letters|January 30, 2017
Discovery of MK-1832, a Kv1.5 inhibitor with improved selectivity and pharmacokineticsScott E Wolkenberg, M Brad Nolt, Mark T Bilodeau, et al.
Genome Biology|December 5, 2024
Increased spatial coupling of integrin and collagen IV in the immunoresistant clear-cell renal-cell carcinoma tumor microenvironmentAlex C Soupir, Mitchell T Hayes, Taylor C Peak, et al.
Journal of Medicinal Chemistry|June 11, 2014
Maximizing diversity from a kinase screen: identification of novel and selective pan-Trk inhibitors for chronic painShawn J Stachel, John M Sanders, Darrell A Henze, et al.
Biorxiv : the Preprint Server for Biology|November 28, 2023
Increased spatial coupling of integrin and collagen IV in the immunoresistant clear cell renal cell carcinoma tumor microenvironmentAlex C Soupir, Mitchell T Hayes, Taylor C Peak, et al.
Pageof 38